Lee RW - Search Results

1

Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes.

Carreño E, Moutray T, Fotis K, Lee RW, Dick AD, Ross AH, Bailey C. Carreño E, et al. Among authors: lee rw. Br J Ophthalmol. 2016 Sep;100(9):1221-6. doi: 10.1136/bjophthalmol-2015-307806. Epub 2015 Dec 16. Br J Ophthalmol. 2016. PMID: 26674776 Clinical Trial.

2

Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.

Hogan AC, McAvoy CE, Dick AD, Lee RW. Hogan AC, et al. Among authors: lee rw. Ophthalmology. 2007 May;114(5):1000-6. doi: 10.1016/j.ophtha.2007.01.026. Ophthalmology. 2007. PMID: 17467532

3

CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids.

Lee RW, Creed TJ, Schewitz LP, Newcomb PV, Nicholson LB, Dick AD, Dayan CM. Lee RW, et al. J Immunol. 2007 Dec 1;179(11):7941-8. doi: 10.4049/jimmunol.179.11.7941. J Immunol. 2007. PMID: 18025242

4

Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.

Rajendram R, Lee RW, Potts MJ, Rose GE, Jain R, Olver JM, Bremner F, Hurel S, Cook A, Gattamaneni R, Tomlinson M, Plowman N, Bunce C, Hollinghurst SP, Kingston L, Jackson S, Dick AD, Rumsey N, Morris OC, Dayan CM, Uddin JM. Rajendram R, et al. Among authors: lee rw. Trials. 2008 Jan 31;9:6. doi: 10.1186/1745-6215-9-6. Trials. 2008. PMID: 18237441 Free PMC article.

5

Mycophenolate mofetil for the treatment of uveitis.

Teoh SC, Hogan AC, Dick AD, Lee RW. Teoh SC, et al. Among authors: lee rw. Am J Ophthalmol. 2008 Nov;146(5):752-60, 760.e1-3. doi: 10.1016/j.ajo.2008.03.004. Epub 2008 May 2. Am J Ophthalmol. 2008. PMID: 18455143

6

Glucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases.

Schewitz LP, Lee RW, Dayan CM, Dick AD. Schewitz LP, et al. Among authors: lee rw. Immunopharmacol Immunotoxicol. 2009;31(1):1-22. doi: 10.1080/08923970802334848. Immunopharmacol Immunotoxicol. 2009. PMID: 19238755

7

Steroid refractory CD4+ T cells in patients with sight-threatening uveitis.

Lee RW, Schewitz LP, Nicholson LB, Dayan CM, Dick AD. Lee RW, et al. Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4273-8. doi: 10.1167/iovs.08-3152. Epub 2009 Apr 1. Invest Ophthalmol Vis Sci. 2009. PMID: 19339737 Free article.

8

Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience.

Sharma SM, Nestel AR, Lee RW, Dick AD. Sharma SM, et al. Among authors: lee rw. Ocul Immunol Inflamm. 2009 Nov-Dec;17(6):403-14. doi: 10.3109/09273940903072443. Ocul Immunol Inflamm. 2009. PMID: 20001261 Review.

9

Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.

Lee RW, Dick AD. Lee RW, et al. Br J Ophthalmol. 2010 Mar;94(3):269-70. doi: 10.1136/bjo.2009.176750. Br J Ophthalmol. 2010. PMID: 20215370 No abstract available.

10

Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.

Lee RW, Dick AD. Lee RW, et al. Eye (Lond). 2012 Jan;26(1):17-28. doi: 10.1038/eye.2011.255. Epub 2011 Sep 30. Eye (Lond). 2012. PMID: 21960067 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters